COCUZZA, CLEMENTINA ELVEZIA
 Distribuzione geografica
Continente #
NA - Nord America 14.460
EU - Europa 7.659
AS - Asia 7.008
SA - Sud America 1.135
AF - Africa 126
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 9
Totale 30.414
Nazione #
US - Stati Uniti d'America 14.157
SG - Singapore 2.534
CN - Cina 1.861
IT - Italia 1.662
DE - Germania 1.393
HK - Hong Kong 1.177
RU - Federazione Russa 1.133
BR - Brasile 892
SE - Svezia 889
IE - Irlanda 852
VN - Vietnam 616
UA - Ucraina 470
GB - Regno Unito 358
CA - Canada 219
KR - Corea 186
ID - Indonesia 165
FI - Finlandia 164
FR - Francia 134
DK - Danimarca 131
AT - Austria 127
NL - Olanda 110
IN - India 102
AR - Argentina 101
BD - Bangladesh 56
PL - Polonia 56
TR - Turchia 56
MX - Messico 55
ZA - Sudafrica 53
JP - Giappone 49
EC - Ecuador 40
IQ - Iraq 33
BE - Belgio 32
ES - Italia 28
CO - Colombia 25
IR - Iran 22
CH - Svizzera 21
CL - Cile 21
PK - Pakistan 19
CZ - Repubblica Ceca 17
PY - Paraguay 17
EU - Europa 14
TN - Tunisia 14
VE - Venezuela 13
IL - Israele 12
PE - Perù 12
RO - Romania 12
MA - Marocco 11
SA - Arabia Saudita 11
UZ - Uzbekistan 11
AE - Emirati Arabi Uniti 10
GR - Grecia 10
PH - Filippine 10
TW - Taiwan 10
DZ - Algeria 9
EG - Egitto 9
LT - Lituania 9
PT - Portogallo 9
AU - Australia 8
ET - Etiopia 8
KE - Kenya 8
UY - Uruguay 8
BG - Bulgaria 7
DO - Repubblica Dominicana 7
MY - Malesia 7
RS - Serbia 7
BO - Bolivia 6
CR - Costa Rica 6
JO - Giordania 6
NP - Nepal 6
AM - Armenia 5
AZ - Azerbaigian 5
KZ - Kazakistan 5
LB - Libano 5
AL - Albania 4
OM - Oman 4
SI - Slovenia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
BB - Barbados 3
HR - Croazia 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LV - Lettonia 3
NO - Norvegia 3
SC - Seychelles 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CY - Cipro 2
GE - Georgia 2
GT - Guatemala 2
HU - Ungheria 2
KH - Cambogia 2
KW - Kuwait 2
MN - Mongolia 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
UG - Uganda 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
Totale 30.391
Città #
Ann Arbor 3.017
Dallas 1.447
Singapore 1.384
Hong Kong 1.158
Frankfurt am Main 1.019
Ashburn 953
Woodbridge 920
Dublin 829
Fairfield 739
Chandler 641
Houston 631
Milan 576
Wilmington 508
Jacksonville 468
Hefei 321
New York 315
Dearborn 314
Santa Clara 305
Beijing 302
Seattle 289
Princeton 233
Cambridge 226
Los Angeles 203
Seoul 172
Ho Chi Minh City 157
Chicago 134
Jakarta 133
Nanjing 132
Hanoi 128
Moscow 120
Vienna 104
Shanghai 99
Lawrence 94
Buffalo 92
Altamura 91
The Dalles 91
São Paulo 90
Rome 78
Lachine 75
Boardman 69
Guangzhou 63
London 61
Munich 55
Council Bluffs 52
Ottawa 44
Shenyang 44
Helsinki 42
San Diego 42
Nuremberg 41
Tokyo 40
Warsaw 37
Toronto 35
Nanchang 34
Montreal 33
Rio de Janeiro 33
Hangzhou 32
Hebei 32
Jinan 32
Stockholm 32
Orem 31
Tianjin 29
Andover 28
Denver 27
Haiphong 27
Lappeenranta 26
Mountain View 26
Brussels 25
Brooklyn 24
Phoenix 24
Turin 24
Atlanta 23
Zhengzhou 23
Brescia 22
Dong Ket 22
Falls Church 22
Fremont 22
Huizen 22
Changsha 21
Chennai 21
Redmond 21
Belo Horizonte 20
Johannesburg 20
Mexico City 20
Norwalk 20
Salt Lake City 20
San Francisco 20
Boston 19
Columbus 19
Kunming 18
Quito 18
Kent 17
Palermo 17
Poplar 17
Amsterdam 16
Ningbo 16
Biên Hòa 15
Da Nang 15
Dhaka 15
Jiaxing 15
Turku 15
Totale 20.303
Nome #
1, 2, 4-oxadiazol compounds active against gram-positive pathogens 1.478
In vitro bactericidal activity of 0.6% povidone-iodine eye drops formulation 553
Human papillomavirus DNA detection in plasma and cervical samples of women with a recent history of low grade or precancerous cervical dysplasia 482
Marine fungi from the sponge Grantia compressa: biodiversity, chemodiversity and biotechnological potential 476
Legionella pneumophila in water: performance of culture method detection carried out by Italian laboratories partecipating to UNICHIM proficiency testing and validation of three molecular methods for quantitative detection 470
4-Alkyliden-azetidinones modified with plant derived polyphenols: Antibacterial and antioxidant properties 421
Analysis of human papillomavirus (HPV) 16 variants associated with cervical infection in Italian women 403
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis 388
Prevalence of human papillomavirus (HPV) and other sexually transmitted infections (STIS) among italian women referred for a colposcopy 348
Factors affecting incidence of bacteremia due to dental extractions [Fattori che influenzano l’incidenza della batteriemia dopo estrazioni dentarie] 340
Bactericidal activity of 0.6% povidone-iodine eye drops formulation in preparation of patients for cataract surgery: preliminary results of a multi-centre, prospective, clinical study 329
One step forwards for the routine use of high-throughput DNA sequencing in environmental monitoring. An efficient and standardizable method to maximize the detection of environmental bacteria 327
Effectiveness of 0.66% Povidone-Iodine Eye Drops on Ocular Surface Flora before Cataract Surgery: A Nationwide Microbiological Study 325
Volatile organic compounds as biomarkers of gastrointestinal diseases and nutritional status 320
Criteria for second generation comparator tests in validation of novel HPV DNA tests for use in cervical cancer screening 304
Evaluation of an environmental transport medium for legionella pneumophila recovery 302
Design, synthesis, and biological evaluation of 4-alkyliden-beta lactams: New products with promising antibiotic activity against resistant bacteria 290
Antimicrobial susceptibility of Listeria monocytogenes isolates from human cases in northern Italy, 2008–2010: MIC determination according to EUCAST broth microdilution method 289
Antibiotic susceptibility of environmental legionella pneumophila strains isolated in northern Italy 287
Potentiation of fluoroquinolone and macrolide activities by efflux pump inhibitory effect on Staphylococcus aureus and Streptococcus pyogenes of new benzyl piperazinyl lysine derivatives 278
Wastewater surveillance of SARS-CoV-2 variants in October-November 2022 in Italy: detection of XBB.1, BA.2.75 and rapid spread of the BQ.1 lineage 276
Exploring the under-investigated "microbial dark matter" of drinking water treatment plants 264
Evaluation of Pre‐Analytical and Analytical Methods for Detecting SARS‐CoV‐2 in Municipal Wastewater Samples in Northern Italy 258
Prevalence of Chlamydia trachomatis Infection, Serovar Distribution and Co-Infections with Seven High-Risk HPV Types among Italian Women with a Recent History of Abnormal Cervical Cytology 256
The Effectiveness of 0.6% Povidone Iodine Eye Drops in Reducing the Conjunctival Bacterial Load and Needle Contamination in Patients Undergoing Anti-VEGF Intravitreal Injection: A Prospective, Randomized Study 248
Prevalence of Plasmid-Mediated Quinolone Resistance Genes in Uropathogenic Escherichia coli Isolated in a Teaching Hospital of Northern Italy 243
New linezolid-like 1,2,4-oxadiazolesactive against Gram-positive multiresistant pathogens 241
Myocardial revascularization with miniaturized extracorporeal circulation versus off pump: Evaluation of systemic and myocardial inflammatory response in a prospective randomized study 241
MRSA infections among patients in the emergency department: A European multicentre study 237
Antibiotic susceptibility of respiratory pathogens recently isolated in Italy: focus on cefditoren 236
Ricerca quantitativa di Epstein-barr virus in campioni di liquor e sangue da pazienti affetti da sclerosi multipla 236
Alternative pre-analytical strategies for SARS CoV 2 RNA detection 236
Inhibition of murine leukemia (WEHI-3B and L1210) proliferation by cholera toxin B subunit 235
Chemical profile, antioxidant and antibacterial activities of achillea moschata wulfen, an endemic species from the alps 232
Quality Assurance in Cervical Cancer Screening: Evaluation of Sample Adequacy in HPV DNA Testing 230
Antibacterial activity of tigemonam dicholate (SQ 30836) and interaction with beta-lactamases of gram-negative bacteria 229
Molecular typing of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis: Comparison of results obtained in a multilaboratory effort using identical protocols and MRSA strains 228
Travel-Related Typhoid Fever: Narrative Review of the Scientific Literature 226
Antibacterial Agents and Cystic Fibrosis: Synthesis and Antimicrobial Evaluation of a Series of N-Thiomethylazetidinones 223
High-risk HPV and Chlamydia trachomatis co-infections in women with cervical dysplasia 223
Prevalence of aac(6 )-Ib-cr gene in Escherichia coli isolated in northern Italy from patients with urinary tract infections 222
Development of solid lipid nanoparticles for antimicrobial drug delivery 222
Distribution of hpv genotypes in patients with a diagnosis of anal cancer in an Italian region 220
Resistance to Linezolid in Staphylococcus spp. clinical isolates associated with ribosomal binding site modifications: Novel Mutation in domain v of 23S rRNA 219
Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7 215
Frequency and clinical significance of human beta-herpesviruses in cervical samples from Italian women 214
Design and Synthesis of 4-Alkylidene-β-lactams: Benzyl- and Phenethyl-carbamates as Key Fragments to Switch on Antibacterial Activity 212
Wastewater Surveillance for SARS-CoV-2 in Northern Italy: An Evaluation of Three Different Gene Targets 211
Italian observational study on HPV infection, E6, and p16 expression in men with penile cancer 210
Antibacterial, antimycotic and trichomonicidal activity of a new nitroimidazole (EU 11100) 208
Synthesis and preliminary antibacterial evaluation of Linezolid-like 1,2,4-oxadiazole derivatives 208
A case of listeria monocytogenes ST-219 meningo-encephalitis 208
Nosocomial transmission of carbapenem-resistant Klebsiella pneumoniae in an Italian university hospital: a molecular epidemiological study 208
Human papillomavirus (HPV) detection in vaginal self-samples: evaluation of eNat® as an alternative suspension medium to ThinPrep®PreservCyt® for vaginal swabs 206
Impact of naturally occurring variation in the human papillomavirus 52 capsid proteins on recognition by type-specific neutralising antibodies 205
New potent antibacterials against Gram-positive multiresistant pathogens: Effects of side chain modification and chirality in linezolid-like 1,2,4-oxadiazoles 204
Serum levels of flurithromycin ethylsuccinate in healthy volunteers 203
Drug development of new N-methylthio-azetidinones and linezolid-like compounds active against Staphylococcus aureus isolated from cystic fibrosis patients: in vitro and in vivo biological evaluation 201
Old and new linezolid-resistance mutations and determinants in coagulase-negative staphylococci in Italy: preliminary evaluation of antibacterial activity of novel linezolid-like 1,2,4-oxadiazole derivates 200
Durability of the neutralizing antibody response to vaccine and non-vaccine HPV types 7 years following immunization with either Cervarix® or Gardasil® vaccine 200
Spotted fever in the Mediterranean 199
Preclinical Development of MiBIECT, a New Oxadiazolyl-Oxazolidinone Compound Active against Gram-positive Cocci 199
Naturally occurring capsid protein variants of human papillomavirus genotype 31 represent a single L1 serotype 199
Evaluation of Human Papilloma Virus (HPV) Genotyping and Viral Load Determination as Diagnostic Biomarkers of Cervical Cancer Risk 198
Tracking the Spread of the BA.2.86 Lineage in Italy Through Wastewater Analysis 196
Clinical performance of the novel full-genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework 194
New tracts of linezolid resistance mutations in coagulase-negative staphylococci in Northern Italy: preliminary antibacterial evaluation of linezolid-like 1,2,4-oxadiazole derivatives 193
Human Papillomavirus Same Genotype Persistence and Risk: A Systematic Review 193
Accuracy of Human Papillomavirus (HPV) Testing on Urine and Vaginal Self-Samples Compared to Clinician-Collected Cervical Sample in Women Referred to Colposcopy 191
Pharmacokinetics of rufloxacin in healthy volunteers after repeated oral doses 191
Antibiotic susceptibility of human and food strains of Listeria monocytogenes isolated in Northern Italy 189
High-Risk Clone of Klebsiella pneumoniae Co-Harbouring Class A and D Carbapenemases in Italy 187
In vitro activity of a new quinolone, rufloxacin, against nosocomial isolates 186
Effect of antibiotics on Bordetella pertussis adhering activity: hypothesis regarding mechanism of action 183
Comparison of Different Self-Sampling Devices for Molecular Detection of Human Papillomavirus (HPV) and Other Sexually Transmitted Infections (STIs): A Pilot Study 183
Evaluation of Trends in Influenza A and B Viruses in Wastewater and Human Surveillance Data: Insights from the 2022–2023 Season in Italy 182
Evaluation of BD Onclarity™ HPV Assay on Self-Collected Vaginal and First-Void Urine Samples as Compared to Clinician-Collected Cervical Samples: A Pilot Study 179
The effects of thymopentin on the development of SLE-like syndrome in the MRL/lpr-lpr mouse 179
Impact of Naturally Occurring Variation in the Human Papillomavirus 58 Capsid Proteins on Recognition by Type-Specific Neutralizing Antibodies 177
Molecular typing of erythromycin-resistant streptococcus pyogenes strains with the M phenotype isolated in Italy 175
Elevated serum levels of interleukin-12 in chronic progressive multiple sclerosis 175
VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples 174
Antimicrobial susceptibility and epidemiological types of Legionella pneumophila human isolates from Italy (1987–2020) 173
Characterisation and clonal analysis of Klebsiella pneumoniae sequence type 258 KPC‐2 positive isolates responsible for a nosocomial outbreak in northern Italy 172
In-vitro activity of ampicillin/sulbactam and other antibiotics against clinical isolates of Haemophilus sp. and Branhamella catarrhalis 171
Evaluation of two alternative non-alcohol-based media for the suspension of self-collected vaginal swabs for HPV testing in cervical cancer screening 170
Prevalence and viral load of oncogenic human papillomavirus types associated with cervical carcinoma in a population of North Italy 170
Gender and age-dependent etiology of community-acquired urinary tract infections 169
Clinical accuracy of OncoPredict HPV Quantitative Typing (QT) assay on self-samples 167
Rufloxacin once daily versus ofloxacin twice daily for treatment of complicated cystitis and upper urinary tract infections. Italian Multicentre UTI Rufloxacin Group 166
Performance of BD Onclarity HPV assay on FLOQSwabs vaginal self-samples 165
Identification and quantification of oncogenic HPV nucleic acids by means of real-time PCR assays 163
Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients 163
Monocyclic β-lactams as antibacterial agents: Facing antioxidant activity of N-methylthio-azetidinones 162
Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania 161
High HPV-51 Prevalence in Invasive Cervical Cancers: Results of a Pre-Immunization Survey in North Sardinia, Italy 161
Effects of pidotimod on macrophage functions in methylprednisolone-treated mice 160
Automated extraction and quantitation of oncogenic HPV genotypes from cervical samples by a real-time PCR-based system 157
Prevalence of the internalization-associated gene prtF1 in a bacterial population of Streptococcus pyogenes isolated from children with acute pharyngotonsillitis before and after antibiotic therapy 157
Effect of quinolones on the production of colony stimulating factors by macrophages 157
Totale 24.490
Categoria #
all - tutte 97.875
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.875


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.878 0 0 0 0 0 279 311 310 259 249 208 262
2021/20222.108 183 195 174 190 128 182 83 99 126 157 193 398
2022/20233.233 399 857 310 307 287 463 43 180 187 49 94 57
2023/20242.417 82 66 67 122 264 540 542 93 185 58 52 346
2024/20256.021 359 591 336 262 415 304 383 276 510 929 604 1.052
2025/20267.959 1.326 1.369 1.967 1.403 1.372 522 0 0 0 0 0 0
Totale 31.204